[Treatment of localized cutaneous leishmaniasis].
Buffet
P
P
Hôpital de la Pitié-Salpêtrière, Département de Médecine tropicale, Maladies infectieuses, Parasitologie-Mycologie et Santé Publique, Paris.
Caumes
E
E
Gentilini
M
M
D000666:Amphotericin B / Q000627:therapeutic use; D000967:Antimony Sodium Gluconate / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D007654:Ketoconazole / Q000627:therapeutic use; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy*; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use; D010419:Pentamidine / Q000627:therapeutic use
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D017964:Itraconazole; D010419:Pentamidine; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000666:Amphotericin B; D007654:Ketoconazole; D000967:Antimony Sodium Gluconate